the significance of tucatinib trastuzumab as a chemotherapy-free option for her2 metastatic btc
Published 1 year ago • 184 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
2:21
sgntuc-019: tucatinib trastuzumab for previously treated her2 metastatic biliary tract cancer
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
0:36
tucatinib & trastuzumab /- chemo or pembrolizumab in unresectable or metastatic her2 gi cancers
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
0:55
her2climb-05: tucatinib with trastuzumab and pertuzumab as maintenance therapy for her2 mbc
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
1:24
tucatinib and trastuzumab in the treatment paradigm of her2-positive mcrc
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
4:14
study of gdc-0084 with trastuzumab in her2-positive breast cancer with brain metastases
-
2:43
margetuximab for the treatment of her2-positive breast cancer
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies